Cel Sci Corp SEC filings CVM
Cel Sci Corp has 1,007 filings in SEC EDGAR's recent list, going back to Jun 12, 2012. Its latest annual report, Form ARS, was filed on Jul 2, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 17, 2026 (shareholder vote results). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| RW | Form rw | May 27, 2026 | — |
| RW | Form rw | May 19, 2026 | — |
| EFFECT | Filing | May 11, 2026 | — |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| DEL AM | Filing | Apr 24, 2026 | — |
| CORRESP | Letter to the SEC | Apr 20, 2026 | — |
| EFFECT | Filing | Dec 3, 2025 | — |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| EFFECT | Filing | Aug 12, 2025 | — |
| CORRESP | Letter to the SEC | Aug 7, 2025 | — |
| CORRESP | Letter to the SEC | Aug 5, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2025 | — |
| DRS | Filing | Jul 25, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2025 | — |
| CORRESP | Letter to the SEC | Mar 3, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 24, 2025 | — |
| NT 10-K | Filing | Dec 30, 2024 | Sep 30, 2024 |
| EFFECT | Filing | Nov 7, 2024 | — |
| CORRESP | Letter to the SEC | Nov 5, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2024 | — |
| AW | Filing | Oct 10, 2024 | — |
| EFFECT | Filing | Jul 15, 2022 | — |
| EFFECT | Filing | Jul 15, 2022 | — |
| CORRESP | Letter to the SEC | Jul 13, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2022 | — |
| EFFECT | Filing | Jan 25, 2021 | — |
| EFFECT | Filing | Jul 10, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2020 | — |
| CORRESP | Letter to the SEC | Jul 8, 2020 | — |
| EFFECT | Filing | Apr 20, 2020 | — |
| CORRESP | Letter to the SEC | Apr 15, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2020 | — |
| EFFECT | Filing | Mar 18, 2020 | — |
| CORRESP | Letter to the SEC | Mar 16, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2020 | — |
| CORRESP | Letter to the SEC | Mar 9, 2020 | — |
| CORRESP | Letter to the SEC | Mar 4, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2020 | — |
| CORRESP | Letter to the SEC | Feb 25, 2020 | — |
| AW | Letter withdraw pos 229295 | Feb 21, 2020 | — |
| AW | Letter withdraw pos 229295 | Feb 21, 2020 | — |
| AW WD | Letter withdraw pos per error | Feb 21, 2020 | — |
| AW | Letter withdraw post-effect amend 233379 | Feb 20, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2020 | — |
| EFFECT | Filing | Aug 30, 2019 | — |
| CORRESP | Letter to the SEC | Aug 27, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2019 | — |
| EFFECT | Filing | Feb 13, 2019 | — |
| CORRESP | Letter to the SEC | Feb 13, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2019 | — |
| 25-NSE | Delisting notice | Oct 9, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2018 | — |
| EFFECT | Filing | Sep 12, 2018 | — |
| CORRESP | Letter to the SEC | Sep 7, 2018 | — |
| EFFECT | Filing | Aug 24, 2018 | — |
| CORRESP | Letter to the SEC | Aug 21, 2018 | — |
| CORRESP | Letter to the SEC | Aug 21, 2018 | — |
| EFFECT | Filing | Aug 17, 2018 | — |
| CORRESP | Letter to the SEC | Aug 15, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2018 | — |
| D | Filing | Jul 11, 2018 | — |
| EFFECT | Filing | Jul 9, 2018 | — |
| CORRESP | Letter to the SEC | Jul 5, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2018 | — |
| EFFECT | Filing | Jun 15, 2018 | — |
| CORRESP | Letter to the SEC | Jun 11, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2018 | — |
| EFFECT | Filing | Feb 28, 2018 | — |
| CORRESP | Letter to the SEC | Feb 23, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 22, 2018 | — |
| EFFECT | Filing | Jan 23, 2018 | — |
| CORRESP | Letter to the SEC | Jan 18, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2018 | — |
| EFFECT | Filing | Sep 1, 2017 | — |
| CORRESP | Letter to the SEC | Aug 29, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2017 | — |
| EFFECT | Filing | Aug 8, 2017 | — |
| CORRESP | Letter to the SEC | Aug 8, 2017 | — |
| CORRESP | Letter to the SEC | Aug 8, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2017 | — |
| D | Filing | Jul 17, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2017 | — |
| CORRESP | Letter to the SEC | Apr 5, 2017 | — |
| PRER14A | Prelim proxy amend. no. 1 | Apr 5, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2017 | — |
| D | Filing | Feb 28, 2017 | — |
| NT 10-K | Sept 2016 10-k 12b-25 | Dec 15, 2016 | Sep 30, 2016 |
| EFFECT | Filing | Oct 30, 2015 | — |
| CORRESP | Letter to the SEC | Oct 28, 2015 | — |
| CT ORDER | Filing | Oct 27, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2015 | — |
| CORRESP | Letter to the SEC | Jul 21, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2015 | — |
| CORRESP | Letter to the SEC | Jun 8, 2015 | — |
| CORRESP | Letter to the SEC | Jun 5, 2015 | — |
| CORRESP | Letter to the SEC | May 27, 2015 | — |
| CORRESP | Letter to the SEC | Apr 20, 2015 | — |
| CORRESP | Letter to the SEC | Apr 10, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2015 | — |
| NT 10-K | 12b-25 for sept. 2014 10-k | Dec 12, 2014 | Sep 30, 2014 |
| EFFECT | Filing | Jul 8, 2014 | — |
| CORRESP | Letter to the SEC | Jul 3, 2014 | — |
| CORRESP | Letter to the SEC | Jun 20, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2014 | — |
| RW | Letter re withraw s-3 191634 | Apr 10, 2014 | — |
| CERTNYS | Auto-generated paper document | Jan 29, 2014 | — |
| 8-A12B | Form 8-a re s warrants | Jan 3, 2014 | — |
| NT 10-K/A | Amended 12b-25 for sept 2013 10-k | Dec 17, 2013 | Sep 30, 2013 |
| NT 10-K | 12b-25 for sept 2013 10-k | Dec 17, 2013 | Sep 30, 2013 |
| PRER14A | Prelim proxy amend #4 | Apr 5, 2013 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2013 | — |
| EFFECT | Filing | Feb 28, 2013 | — |
| CORRESP | Letter to the SEC | Feb 28, 2013 | — |
| PRER14A | Preliminary proxy statement amendment no. 3 | Feb 28, 2013 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2013 | — |
| CORRESP | Letter to the SEC | Feb 27, 2013 | — |
| CORRESP | Letter to the SEC | Feb 26, 2013 | — |
| PRER14A | Prelim proxy amend #2 | Feb 26, 2013 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2013 | — |
| CORRESP | Letter to the SEC | Feb 22, 2013 | — |
| UPLOAD | Letter from the SEC | Feb 20, 2013 | — |
| PRER14A | Prelim proxy amend #1 | Feb 15, 2013 | — |
| CORRESP | Letter to the SEC | Feb 8, 2013 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2013 | — |
| EFFECT | Filing | Oct 5, 2012 | — |
Showing 132 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CVM (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- CO
- Headquarters
- Vienna, VA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 725363
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.